Baylor Genetics is #hiring a Senior Benefits Analyst to support our employee benefit and leave programs. If you have experience in benefits administration and value accurate, employee-focused service, we’d love to hear from you.

Apply today: recruiting2.ultipro.com/BAY1006BML/Job…

#JobSearch

New research at #NSGC26: Sydney Lau, MS, CGC, will share findings on hearing loss & immunodeficiency, highlighting how genome & exome sequencing can improve diagnostic outcomes & identify variants missed by panel testing. Visit us at booth 1376: baylorgenetics.com/conferences/ns…

#GeneChat

Next week, we’re heading to #NSGC26! Join us throughout #NSGC26 to connect and explore the evolving role of genomic technologies in supporting care throughout the patient journey.

Visit us at booth 1376 to connect with our team: baylorgenetics.com/conferences/ns…

#GeneChat @GeneticCouns

A recent study found a ~38% diagnostic yield with #genome and exome sequencing in children with leukodystrophies and leukoencephalopathies.

Watch to learn how #GenomeSequencing can identify additional variant types and inform testing strategies.

Designed with providers in mind, the Baylor Genetics Provider Portal now offers a more intuitive, efficient experience with faster ordering, reduced manual data entry, enhanced search, & customizable dashboard views. Explore the updates: baylorgenetics.com

Whole Genome Sequencing is changing how providers approach genetic testing.

In this video, Russ Talley discusses the shift toward a genome-first approach and what it can mean for delivering answers to patients sooner.

#GenomeSequencing #Genomics

Emerging genomic technologies are expanding opportunities for diagnosis. Join our #NSGC26 lunch symposium to explore how genome-first strategies & complementary technologies can provide insights across prenatal, neonatal, & postnatal care. baylorgenetics.com/conferences/ns…
#NSGC #GeneChat

In a study of 650+ children, Baylor Genetics’ Whole Genome Sequencing provided a genetic diagnosis for nearly one-third (31.1%) of patients.

Read our latest blog on the clinical value of using genome sequencing earlier in the diagnostic odyssey: baylorgenetics.com/blog/study-hig…

Baylor Genetics is joining #BeckersHealthcare 14th Annual CEO + CFO Roundtable to discuss the value of genomics across health systems.

Join our featured session to explore how genome sequencing can support better clinical outcomes & more efficient operations.

#BeckersCEOCFO

Thank you to everyone who connected with us at #ASHG26! We were proud to share research advancing genomic diagnosis for individuals with rare and complex conditions.

If we missed you, we’d love to connect: baylorgenetics.com/contact/

#ASHG #Genomics @GeneticsSociety

Baylor Genetics is proud to sponsor the Epilepsy Foundation’s inaugural Genetic Testing Research Roundtable for Epilepsy, bringing together clinicians, researchers, and advocates to advance genetic testing research and address barriers to access in #epilepsy care. @EpilepsyFdn

At #ASHG26, Baylor Genetics is presenting research on the diagnostic utility of genome sequencing, developmental and epileptic encephalopathy, and clinical mitochondrial testing.

Visit booth #500 to connect with our team and learn more: baylorgenetics.com/conferences/as…

@GeneticsSociety

Join the Cerebral Palsy Research Network tomorrow, October 22, at 8 pm ET for a webinar on the evolving role of genetics in cerebral palsy and what new insights might mean for families.

Register: cprn.org/portfolio-item…

#Webinar #CerebralPalsy

Thank you to everyone who connected with us at #CNSAM in Montréal. We appreciated the conversations around how genomic testing can help uncover answers & inform care for patients with neurological conditions. baylorgenetics.com/news/baylor-ge…

At #ASHG26, Baylor Genetics will present new data highlighting the clinical and diagnostic utility of genome sequencing for rare and complex genetic conditions. Visit booth #500 to connect with our team.

Learn more: baylorgenetics.com/news/baylor-ge…

We're in Montréal for #CNSAM! Stop by booth #500 to meet our team and learn how genomic testing is helping uncover answers for patients with complex neurological conditions. baylorgenetics.com/conferences/cn…

#Neurology #CNS2026 @ChildNeuroSoc

New research from Baylor Genetics adds to growing evidence supporting WGS as a first-tier test for children with intellectual disability & developmental delay. In a study of 650+ pediatric patients, WGS delivered a diagnosis in 31.1% of cases: baylorgenetics.com/news/baylor-ge…

#CNSAM

We're proud to be at CNS 2026, sharing research on genome sequencing utilization and the diagnostic utility of genome and exome sequencing for pediatric leukodystrophies. Visit booth #500: baylorgenetics.com/conferences/cn…

#PediatricNeurology #CNSAM

At #CNSAM, Baylor Genetics will highlight the growing role of genome sequencing in pediatric neurology through a satellite symposium and research posters.

Visit booth #500 to learn how genomic testing is helping inform precision neurology: baylorgenetics.com/news/baylor-ge…

Advances in genomics are expanding what's possible in pediatric neurology. As an official genetic testing partner of @ChildNeuroSoc, Baylor Genetics is proud to join #CNSAM in Montréal. Visit us at booth #500 and join our lunch symposium on Oct. 14: baylorgenetics.com/conferences/cn…